Integra LifeSciences Holdings Corporation (NASDAQ: IART) is one of 84 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it weigh in compared to its rivals? We will compare Integra LifeSciences Holdings Corporation to similar businesses based on the strength of its earnings, institutional ownership, analyst recommendations, profitability, valuation, dividends and risk.

Volatility & Risk

Integra LifeSciences Holdings Corporation has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500. Comparatively, Integra LifeSciences Holdings Corporation’s rivals have a beta of 1.06, meaning that their average share price is 6% more volatile than the S&P 500.

Valuation & Earnings

This table compares Integra LifeSciences Holdings Corporation and its rivals top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Integra LifeSciences Holdings Corporation $1.05 billion $240.98 million 61.98
Integra LifeSciences Holdings Corporation Competitors $827.23 million $159.50 million 41.53

Integra LifeSciences Holdings Corporation has higher revenue and earnings than its rivals. Integra LifeSciences Holdings Corporation is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Integra LifeSciences Holdings Corporation and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Integra LifeSciences Holdings Corporation 6.27% 16.79% 7.35%
Integra LifeSciences Holdings Corporation Competitors -132.49% -36.58% -10.54%

Analyst Recommendations

This is a summary of current ratings for Integra LifeSciences Holdings Corporation and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integra LifeSciences Holdings Corporation 0 2 7 0 2.78
Integra LifeSciences Holdings Corporation Competitors 178 1138 2492 89 2.64

Integra LifeSciences Holdings Corporation presently has a consensus price target of $53.56, indicating a potential upside of 5.38%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 8.07%. Given Integra LifeSciences Holdings Corporation’s rivals higher possible upside, analysts clearly believe Integra LifeSciences Holdings Corporation has less favorable growth aspects than its rivals.

Insider & Institutional Ownership

84.9% of Integra LifeSciences Holdings Corporation shares are held by institutional investors. Comparatively, 66.2% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by institutional investors. 21.5% of Integra LifeSciences Holdings Corporation shares are held by company insiders. Comparatively, 10.9% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Integra LifeSciences Holdings Corporation beats its rivals on 9 of the 13 factors compared.

About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions. It sells products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care. It also sells regenerative technology products for treating acute wounds, such as burns, and chronic wounds, including diabetic foot ulcers and surgical tissue repair. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery.

Receive News & Ratings for Integra LifeSciences Holdings Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integra LifeSciences Holdings Corporation and related companies with MarketBeat.com's FREE daily email newsletter.